Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Havrdova

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Plos One|January 13, 2017
Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNβJana Libertinova, Eva Meluzinova, Ales Tomek, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 24, 2013
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM studyMariko Kita, Robert J Fox, J Theodore Phillips, et al.
Journal of Neuroimmunology|August 7, 2013
Interactions of serum cholesterol with anti-herpesvirus responses affect disease progression in clinically isolated syndromesBianca Weinstock-Guttman, Dana Horakova, Robert Zivadinov, et al.
Current Medical Research and Opinion|October 3, 2007
Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosisDouglas S Goodin, Louis D Biermann, Saeed Bohlega, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2016
The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosisDiego Cadavid, Jeffrey A Cohen, Mark S Freedman, et al.
Neurology|October 14, 2016
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patientsGavin Giovannoni, Jeffrey A Cohen, Alasdair J Coles, et al.
Journal of Neurology|June 23, 2014
Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndromeTomas Uher, Jana Blahova-Dusankova, Dana Horakova, et al.
Neurology and Therapy|December 15, 2015
Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing ExperienceRalf Gold, J Theodore Phillips, Eva Havrdova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2011
Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b studyLudwig Kappos, Ralf Gold, David H Miller, et al.
Journal of Neuroimmunology|June 9, 2014
Humoral responses to herpesviruses are associated with neurodegeneration after a demyelinating event: results from the multi-center set studyRobert Zivadinov, Jamie Chin, Dana Horakova, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Plos One|January 13, 2017
Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNβJana Libertinova, Eva Meluzinova, Ales Tomek, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 24, 2013
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM studyMariko Kita, Robert J Fox, J Theodore Phillips, et al.
Journal of Neuroimmunology|August 7, 2013
Interactions of serum cholesterol with anti-herpesvirus responses affect disease progression in clinically isolated syndromesBianca Weinstock-Guttman, Dana Horakova, Robert Zivadinov, et al.
Current Medical Research and Opinion|October 3, 2007
Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosisDouglas S Goodin, Louis D Biermann, Saeed Bohlega, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2016
The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosisDiego Cadavid, Jeffrey A Cohen, Mark S Freedman, et al.
Neurology|October 14, 2016
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patientsGavin Giovannoni, Jeffrey A Cohen, Alasdair J Coles, et al.
Journal of Neurology|June 23, 2014
Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndromeTomas Uher, Jana Blahova-Dusankova, Dana Horakova, et al.
Neurology and Therapy|December 15, 2015
Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing ExperienceRalf Gold, J Theodore Phillips, Eva Havrdova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2011
Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b studyLudwig Kappos, Ralf Gold, David H Miller, et al.
Journal of Neuroimmunology|June 9, 2014
Humoral responses to herpesviruses are associated with neurodegeneration after a demyelinating event: results from the multi-center set studyRobert Zivadinov, Jamie Chin, Dana Horakova, et al.
Pageof 13